FI884291A - Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi - Google Patents

Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi Download PDF

Info

Publication number
FI884291A
FI884291A FI884291A FI884291A FI884291A FI 884291 A FI884291 A FI 884291A FI 884291 A FI884291 A FI 884291A FI 884291 A FI884291 A FI 884291A FI 884291 A FI884291 A FI 884291A
Authority
FI
Finland
Prior art keywords
coating materials
preparing
agents
composition
biologically active
Prior art date
Application number
FI884291A
Other languages
English (en)
Swedish (sv)
Other versions
FI884291A0 (fi
FI95538C (fi
FI95538B (fi
Inventor
Young W Cho
Original Assignee
Eurasiam Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurasiam Lab filed Critical Eurasiam Lab
Publication of FI884291A publication Critical patent/FI884291A/fi
Publication of FI884291A0 publication Critical patent/FI884291A0/fi
Application granted granted Critical
Publication of FI95538B publication Critical patent/FI95538B/fi
Publication of FI95538C publication Critical patent/FI95538C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
FI884291A 1986-03-21 1988-09-19 Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi FI95538C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84262586A 1986-03-21 1986-03-21
PCT/US1987/000485 WO1987005505A1 (en) 1986-03-21 1987-03-12 Pharmaceutical compositions

Publications (4)

Publication Number Publication Date
FI884291A true FI884291A (fi) 1988-09-19
FI884291A0 FI884291A0 (fi) 1988-09-19
FI95538B FI95538B (fi) 1995-11-15
FI95538C FI95538C (fi) 1996-02-26

Family

ID=25287846

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884291A FI95538C (fi) 1986-03-21 1988-09-19 Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi

Country Status (16)

Country Link
EP (1) EP0302065B1 (fi)
JP (1) JPH01500589A (fi)
KR (1) KR900001074B1 (fi)
CN (1) CN87103560A (fi)
AT (1) ATE109659T1 (fi)
AU (1) AU608756B2 (fi)
CA (1) CA1281645C (fi)
DE (1) DE3750369T2 (fi)
FI (1) FI95538C (fi)
HK (1) HK88696A (fi)
HU (1) HU207452B (fi)
IE (1) IE65667B1 (fi)
PT (1) PT84537A (fi)
RU (1) RU1814559C (fi)
WO (1) WO1987005505A1 (fi)
ZA (1) ZA872018B (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
CA1337274C (en) * 1988-09-27 1995-10-10 Shunichi Itoh Enteric film and preparation thereof
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5439967A (en) * 1991-09-17 1995-08-08 Micro Vesicular Systems, Inc. Propylene glycol stearate vesicles
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
WO1998009645A1 (fr) * 1996-09-04 1998-03-12 Dott Research Laboratory Compositions medicamenteuses contenant des peptides, destinees a l'administration orale
EP1115389B1 (en) 1998-09-25 2014-03-12 PhilERA New Zealand Limited Fructosamine oxidase: antagonists and inhibitors
CA2343357A1 (en) 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase assay: methods and materials
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
WO2000022909A2 (en) * 1998-10-19 2000-04-27 Biotech Australia Pty. Limited Systems for oral delivery
US6884792B2 (en) 1999-01-08 2005-04-26 Marvin B. Bacaner Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
ATE290857T1 (de) 1999-01-08 2005-04-15 Marvin B Bacaner Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
CN1141974C (zh) * 2000-06-07 2004-03-17 张昊 结肠定位释放的口服生物制剂
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
JP2003001090A (ja) * 2001-06-22 2003-01-07 Pauretsuku:Kk 流動層装置
JP5595626B2 (ja) * 2001-06-22 2014-09-24 株式会社パウレック コーティング装置
ATE555782T1 (de) 2002-03-08 2012-05-15 Philera New Zealand Ltd Prävention und/oder behandlung von kardiovaskulären erkrankungen und/oder damit zusammenhängender herzinsuffizienz
CA2496411A1 (en) 2002-08-20 2004-03-04 Protemix Corporation Limited Dosage forms and related therapies
DK1778618T3 (da) 2004-07-19 2014-03-10 Philera New Zealand Ltd Syntese af triethylentetraminer
CA2677989C (en) * 2007-02-20 2018-04-24 Eurand Pharmaceuticals Limited Stable digestive enzyme compositions
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
MX348118B (es) 2010-10-01 2017-05-26 Aptalis Pharma Ltd Formulaciones de pancrelipasa con recubrimiento enterico de baja potencia.
EP2987499B1 (en) 2011-08-08 2019-05-08 Allergan Pharmaceuticals International Limited Method for dissolution testing of solid compositions containing digestive enzymes
RU2519099C1 (ru) * 2012-11-08 2014-06-10 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Фармацевтическая композиция
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
RU2679832C2 (ru) 2013-08-09 2019-02-13 Аллерган Фармасьютикалз Интернэйшнл Лимитед Композиция пищеварительных ферментов, подходящая для энтерального введения
JP7233852B2 (ja) * 2018-04-17 2023-03-07 キョーリンリメディオ株式会社 変色が抑制された固形製剤
WO2020026570A1 (ja) * 2018-07-31 2020-02-06 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
JP6612004B1 (ja) * 2018-07-31 2019-11-27 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
WO2020026471A1 (ja) * 2018-07-31 2020-02-06 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
JP6823212B1 (ja) 2020-01-31 2021-01-27 株式会社中田製作所 スクイズ装置
WO2023017537A1 (en) 2021-08-12 2023-02-16 Celagenex Research (India) Pvt. Ltd. Oral algal oil based gastro-intestinal tract permeable peptide composition
CN114313354B (zh) * 2021-12-29 2022-11-08 江南大学 一种基于红外加热的液体微胶囊固化装置及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
GB1155036A (en) * 1966-07-08 1969-06-11 Ethan Allan Brown Injectionable Substance
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4447412A (en) * 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms

Also Published As

Publication number Publication date
ATE109659T1 (de) 1994-08-15
HK88696A (en) 1996-05-31
JPH01500589A (ja) 1989-03-01
IE870696L (en) 1987-09-21
FI884291A0 (fi) 1988-09-19
EP0302065B1 (en) 1994-08-10
HUT48821A (en) 1989-07-28
AU608756B2 (en) 1991-04-18
RU1814559C (ru) 1993-05-07
FI95538C (fi) 1996-02-26
DE3750369T2 (de) 1995-05-24
KR900001074B1 (ko) 1990-02-26
WO1987005505A1 (en) 1987-09-24
KR870008587A (ko) 1987-10-19
DE3750369D1 (de) 1994-09-15
ZA872018B (en) 1988-02-24
PT84537A (en) 1987-04-01
EP0302065A4 (en) 1990-09-12
JPH0576928B2 (fi) 1993-10-25
EP0302065A1 (en) 1989-02-08
HU207452B (en) 1993-04-28
IE65667B1 (en) 1995-11-15
AU7207387A (en) 1987-10-09
FI95538B (fi) 1995-11-15
CN87103560A (zh) 1988-05-18
CA1281645C (en) 1991-03-19

Similar Documents

Publication Publication Date Title
FI95538B (fi) Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi
CA2013755A1 (en) Medicinal emulsions
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
HK1006806A1 (en) Pulmonary administration of pharmaceutically active substances
RU94045129A (ru) Состав для похудения для местного применения, содержащий два типа липосом, и способ уменьшения и/или устранения полноты и/или избыточного веса
GR860066B (en) Process for the preparation of drug-containing chlorofluorocarbon aerosol propellent formulations
IT9021091A0 (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composi- zioni ottenute
FI973452A0 (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
DK0774959T3 (da) Liposomalt indgivelsessystem for biologisk aktive midler
EA199900751A1 (ru) Фармацевтическая композиция, содержащая лиофилизированные липосомы, включающие инкапсулированный активный ингредиент, практически нерастворимый в воде, и способ получения композиции
GR920300128T1 (en) Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance
ATE342049T1 (de) Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen
NO965244D0 (no) Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.
BG103739A (en) Aqueous pharmaceutical composition containing hard soluble active substance in water
EP0335446A3 (en) Agents for treating neoplasms
ES2139881T3 (es) Formulacion acuosa de liberacion retardada.
ATE71529T1 (de) Pharmazeutische praeparate zur transdermalen applikation von heparin.
KR900012613A (ko) 경구 투여용 의약조성물
DK0527720T3 (da) Terapeutiske midler
UA29770A (uk) Спосіб пригнічення репродукції вірусу імунодефіциту людини

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: EURASIAM LABORATORIES, INC.